Subscribe to RSS
DOI: 10.1055/a-1652-5960
Aerosoltherapie auf Intensivstation
Aerosol Therapy in Intensive Care Unit
Zusammenfassung
Die Inhalationstherapie stellt v. a. bei pneumologischen Grund- oder Begleiterkrankungen sowohl bei invasiver als auch nichtinvasiver Beatmung häufig einen Eckpfeiler der Therapie dar, überwiegend in Form einer antiobstruktiven Therapie bei Asthma und COPD. Daneben wird im pädiatrischen Bereich beim respiratorischen Versagen infolge Frühgeburtlichkeit häufig Surfactant vernebelt. Weitere Medikamente sind inhalativ verabreichte Antibiotika, Sekretolytika sowie Substanzen zur Senkung des Pulmonalisdrucks. Der vorliegende Artikel fokussiert auf die Erwachsenen-Medizin und gibt Empfehlungen für eine korrekte Durchführung der Inhalationstherapie sowohl bei invasiver als auch nichtinvasiver Beatmung auf der Intensivstation. Ebenso werden Aspekte der Sicherheit von Patient und Personal während der Inhalationsphasen im Zusammenhang mit der aktuellen Corona-Epidemie besprochen.
Abstract
Inhalation therapy is a cornerstone especially in pulmonary diseases or comorbidities, either in invasive or noninvasive mechanical ventilation. In pediatric patients, mainly in respiratory failure of the premature born child inhalation of surfactant is crucial in the therapy. Additional drugs given by inhalation are antibiotics, mucoactive substances and drugs that treat pulmonary hypertension. This article describes main deposition mechanisms of inhalation therapies and presents recommendations for correct performance of inhalation therapy in invasively as well as noninvasively ventilated patients in ICU. Also safety aspects for patients and medical staff during aerosol therapy in the Corona pandemic era are discussed.
Publication History
Article published online:
22 April 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Ehrmann S, Roche-Campo F, Bodet-Contentin L. et al. Aerosol therapy in intensive and intermediate care units: prospective observation of 2808 critically ill patients. Intensive Care Med 2016; 42: 192-201 DOI: 10.1007/s00134-015-4114-5.
- 2 Köhler D, Fleischer W. Theorie und Praxis der Inhalationstherapie. München: Arcis Verlag; 2000. ISBN: 13: 9783890751405
- 3 Canisius S, Scheuch G. Grundlagen der Aerosoltherapie. Atemw Lungenkh 2016; 42: 481-486 DOI: 10.5414/ATX02116.
- 4 Dhand R. Aerosol delivery during mechanical ventilation: from basic techniques to new devices. J Aerosol Med Pulm Drug Deliver 2008; 21: 45-60 DOI: 10.1089/jamp.2007.0663.
- 5 Dhand R. Aerosol therapy in patients receiving noninvasive positive pressure ventilation. J Aerosol Med Pulm Drug Deliv 2012; 25: 63-78 DOI: 10.1089/jamp.2011.0929.
- 6 Dhand R, Tobin MJ. Bronchodilator delivery with metered-dose inhalers in mechanically-ventilated patients. Eur Respir J 1996; 9: 585-595 DOI: 10.1183/09031936.96.09030585.
- 7 Restrepo RD, Walsh BK. Humidification during invasive and noninvasive mechanical ventilation: 2012. AARC Clinical Practice Guideline. Respir Care 2012; 57: 782-788 DOI: 10.4187/respcare.01766.
- 8 Rochwerg B, Brochard L, Elliott MW. et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017; 50: 1602426 DOI: 10.1183/13993003.02426-2016.
- 9 Ari A, Fink JB, Dhand R. Inhalation therapy in patients receiving mechanical ventilation: an update. J Aerosol Med Pulm Drug Deliv 2012; 25: 319-332
- 10 Lange CF, Finlay WH. Overcoming the adverse effect of humidity in aerosol delivery via pressurized metered-dose inhalers during mechanical ventilation. Am J Respir Crit Care Med 2000; 161: 1614-1618 DOI: 10.1164/ajrccm.161.5.9909032.
- 11 Haidl P, Heindl S, Siemon K. et al. Inhalation device requirements for patientsʼ inhalation maneuvers. Respir Med 2016; 118: 65-75 DOI: 10.1016/j.rmed.2016.07.013.
- 12 Dhand R. Inhalation Therapy With Metered-Dose Inhalers and Dry Powder Inhalers in Mechanically Ventilated Patients. Respir Care 2005; 50: 1331-1344
- 13 Mönig O, Haidl P. eigene Daten, unveröffentlicht.
- 14 Voshaar TH, Haidl P, Cloes R. Spacer. Aerosoltherapie durch Raum und Zeit. Pneumologie 2017; 71: 437-453 DOI: 10.1055/s-0043-109628.
- 15 Boukhettala N, Poree T, Diot P. et al. In vitro performance of spacers for aerosol delivery during adult mechanical ventilation. J Aerosol Med Pulm Drug Deliver 2015; 28: 130-136 DOI: 10.1089/jamp.2013.1091.
- 16 Guerin C, Chevre A, Dessirier P. et al. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1036-1042
- 17 Dellweg D, Wachtel H, Höhn E. et al. In vitro validation of a Respimat® adapter for delivery of inhaled bronchodilators during mechanical ventilation. J Aerosol Med Pulm Drug Deliver 2011; 24: 1-8 DOI: 10.1089/jamp.2011.0883.
- 18 Li J, Zhao M, Hadeer M. et al. Dose Response to Transnasal Pulmonary Administration of Bronchodilator Aerosols via Nasal High-Flow Therapy in Adults with Stable Chronic Obstructive Pulmonary Disease and Asthma. Respiration 2019; 98: 401-409 DOI: 10.1159/000501564.
- 19 Ari A, Atalay OT, Harwood R. et al. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care 2010; 55: 845-851
- 20 Dugernier J, Wittebole X, Roeseler J. et al. Influence of inspiratory flow pattern and nebulizer position on aerosol delivery with a vibrating-mesh nebulizer during invasive mechanical ventilation: an in vitro analysis. Aerosol Med Pulm Drug Deliver 2015; 27: 229-236 DOI: 10.1089/jamp.2014.1131.
- 21 Branconnier MP, Hess DR. Albuterol delivery during noninvasive ventilation. Respir Care 2005; 50: 1649-1653
- 22 Berlinski A, Willis JR. Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model. Respir Care 2013; 58: 1124-1133
- 23 Ehrmann S, Lyazidi A, Louis B. et al. Ventilator-integrated jet nebulization systems: tidal volume control and efficiency of synchronization. Respir Care 2014; 59: 1508-1516 DOI: 10.4187/respcare.02637.
- 24 Mojoli F, Iotti GA, Imberti R. et al. The importance of protecting the mechanical ventilator during colistin methanesulfonate nebulization. Intensive Care Med 2013; 39: 535-536 DOI: 10.1007/s00134-012-2778-7.
- 25 van Meenem DMP, van der Hoegen SM, Binnekade JM. et al. Effect of on-Demand vs routine nebulization of acetylcysteine with salbutamol on ventilator-free days in intensive care units patients receiving invasive ventilation: a randomized clinical trial. JAMA 2018; 319: 993-1001 DOI: 10.1001/jama.2018.0949.
- 26 França E, Dornelas de Andrade AF, Cabral G. et al. Nebulization associated with bi-level noninvasive ventilation: analysis of pulmonary radioaerosol deposition. Respir Med 2006; 100: 721-728 DOI: 10.1016/j.rmed.2005.07.012.
- 27 Hess DR. The mask for noninvasive ventilation: principles of design and effects on aerosol delivery. J Aerosol Med 2007; 20 (Suppl. 01) S85-S99 DOI: 10.1089/jam.2007.0547.
- 28 Galindo-Filho VC, Alcoforado L, Rattes C. et al. A mesh nebulizer is more effective than jet nebulizer to nebulize bronchodilators during non-invasive ventilation of subjects with COPD: A randomized controlled trial with radiolabeled aerosols. Respir Med 2019; 153: 60-67 DOI: 10.1016/j.rmed.2019.05.016.
- 29 Goode ML, Fink JB, Dhand R. et al. Improvement in aerosol delivery with helium-oxygen mixture during mechanical ventilation. Am J Respir Crit Care Med 2001; 163: 109-114 DOI: 10.1164/ajrccm.163.1.2003025.
- 30 Katz I, Pichelin M, Montesanto S. et al. Using Helium-Oxygen to improve regional deposition of inhaled particles. J Aerosol Med Pulm Drug Deliver 2014; 27: 1-10 DOI: 10.1089/jamp.2013.1072.
- 31 Ari A. Pracitical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir Med 2020; 167: 105987 DOI: 10.1016/j.rmed.2020.105987.